glp 1 and eating disorders 504: Adult in the GLP-1 Era Glp1 Use Higher in Eating
Description
Retatrutide's discontinuation rate in SURMOUNT-5 was 12.4%, compared to 7.1% for tirzepatide in SURMOUNT-1 and 4.5% for semaglutide in STEP 1
2023;72(Supplement_1) doi: 10.2337/db23-128-OR

It has an immense amount of longitudinal data re obesity & claims cost

Can GLP-1 Drugs Improve Overall HS Severity
